Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
News releases from Forte Biosciences, Inc.
Forte Biosciences, Inc. Announces 4Q and Full Year 2020 Results and Provides a General Business Update
March 24, 2021
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company announces fourth quarter and full year 2020 results and provides a general business update on...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. to Announce 4Q and Full Year 2020 Results and Provide a General Business Update
March 17, 2021
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, will be providing 4Q and full year 2020 results and provide a general business update on March...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. to Present at the Chardan Annual Microbiome Medicines Summit on March 8th
February 23, 2021
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, announced today that Paul Wagner, Ph.D., CEO of Forte Biosciences will be presenting at the...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. to Present at the Cowen Annual Health Care Conference on March 1st
February 18, 2021
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, announced today announced that Paul Wagner, Ph.D., CEO of Forte Biosciences will be presenting...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
February 12, 2021
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the issuance of equity inducement awards as required by the Nasdaq Stock Market...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. to Present at the Evercore ISI 3rd Annual HealthCONx Conference on December 3rd
November 24, 2020
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, announced today announced that Paul Wagner, Ph.D., CEO of Forte Biosciences will be presenting...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules
November 16, 2020
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the issuance of an equity inducement award as required by the Nasdaq Stock...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th
November 10, 2020
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, announced today announced that Paul Wagner, Ph.D., CEO of Forte Biosciences will be presenting...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. Announces Third Quarter 2020 Results and Provides General Business Update
November 09, 2020
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced third quarter 2020 financial results and provided a general business update.
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. to Announce Third Quarter 2020 Results on November 9
November 02, 2020
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced that it will release third quarter 2020 results after the market close on...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences Announces Closing of $46.0 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
November 02, 2020
Forte Biosciences, Inc. (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, announced today the closing of its previously announced underwritten public offering of an aggregate of 1,614,035...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences Announces Pricing of $40.0 Million Public Offering of Common Stock
October 29, 2020
FORTE BIOSCIENCES ANNOUNCES PRICING OF $40.0 MILLION PUBLIC OFFERING OF COMMON STOCK
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences Announces Proposed Public Offering of Common Stock
October 28, 2020
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of its common stock. In...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. Announces the FDA Has Granted Fast Track Designation to FB-401 for the Treatment of Atopic Dermatitis
October 26, 2020
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules
October 16, 2020
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the issuance of an equity inducement award as required by the Nasdaq Stock...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. Announces First Patient Dosed in the Clinical Trial of FB-401 for the Treatment of Children and Adults With Atopic Dermatitis
September 29, 2020
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced that the first patient has been dosed in the clinical trial of FB-401 for the...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. Announces Full Publication of Phase 1/2 Data in Science Translational Medicine
September 09, 2020
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the publication in Science Translational Medicine of the full results of the...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
August 25, 2020
Forte Biosciences, Inc. (NASDAQ: FBRX) (www.fortebiorx.com), a clinical-stage biopharmaceutical company, today announced the issuance of an equity inducement award as required by the Nasdaq Stock...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. Announces Second Quarter 2020 Results and Provides General Business Update
August 10, 2020
Forte Biosciences, Inc. Announces Second Quarter 2020 Results and Provides General Business Update
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. to Announce Second Quarter 2020 Results on August 10
August 03, 2020
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, announced today that it will release second quarter 2020 results after the market close on...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules
July 28, 2020
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the issuance of equity inducement awards as required by the Nasdaq Stock Market...
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. Announces Issuance of New U.S. Patent
June 18, 2020
FORTE BIOSCIENCES, INC. ANNOUNCES ISSUANCE OF NEW U.S. PATENT
Tickers
FBRX
From
Business Wire News Releases
Forte Biosciences, Inc. Announces Closing of Merger With Tocagen
June 15, 2020
Forte Biosciences, Inc. (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced merger with Tocagen Inc. (previously trading on NASDAQ under...
From
Business Wire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.